United Therapeutics Statistics
NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
554.73-4.37 (-0.78%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
United Therapeutics by the numbers
United Therapeutics has a market capitalization of $23.63 billion based on 42.59M shares outstanding. Its trailing P/E ratio is 20.9, above the 4-company peer median of 15.0, and its forward P/E is 17.4. The stock trades 0.9% above its 50-day average and 2.8% above its 200-day average.
Average daily trading volume is 702.78K shares, or about $389.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
UTHR valuation vs. peer median
| Metric | UTHR | Peer median | Difference |
|---|---|---|---|
| Market cap | $23.63B | $25.26B | -6% |
| P/E (TTM) | 20.9 | 15.0 | +39% |
| Forward P/E | 17.4 | 17.5 | -0% |
| Avg. volume | 702.78K | 3.63M | -81% |
Peer median across 8 companies: VTRS, ROIV, ALNY, INSM, ASND, GMAB, ZTS, BBIO.
Valuation
- Market cap
- $23.63B
- P/E (TTM)
- 20.94
- Forward P/E
- 17.44
- Price / sales (latest FY)
- 7.42
- EPS (TTM)
- $26.49
- Shares outstanding
- 42.59M
Price and trading
- Previous close
- 559.10
- Open
- 561.20
- Day range
- 551.77 – 563.11
- 52-week range
- 455.63 – 614.23
- 52-week change
- +16.83%
- 50-day moving average
- 550.00
- 200-day moving average
- 539.85
- Beta
- —
- Volume
- 367.68K
- Average volume
- 702.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 23.63B
- Pe
- 20.94
- Forward Pe
- 17.44
- Eps
- 26.49
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 614.23
- Week52 Low
- 455.63
- Avg Volume
- 702.78K
- Shares Outstanding
- 42.59M
- Ma50
- 550.00
- Ma200
- 539.85
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -9.69%
- Pct From52w Low
- 21.75%